Inhibitory effect of melatonin on α1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats

American Journal of Hypertension

Volumn 17, Issue 4, 2004, Pages 339-346

  Girouard, Hélène ^a   De Champlain, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

1 adrenergic pathway; Melatonin; Mesenteric artery; Spontaneously hypertensive rats; Superoxide anion

Indexed keywords

2 IODOMELATONIN; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CATALASE; INOSITOL PHOSPHATE; LUCIGENIN; MELATONIN; PHENYLEPHRINE; SCAVENGER; SUPEROXIDE; TEMPOL;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HORMONAL REGULATION; MESENTERIC ARTERY; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERTENSION; INOSITOL PHOSPHATES; MELATONIN; MESENTERIC ARTERIES; MODELS, CARDIOVASCULAR; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENYLEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPLANCHNIC CIRCULATION; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASOCONSTRICTION;

EID: 1842457763     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.12.013     Document Type: Article

References (35)

1. Chuang J.I., Chen S.S., Lin M.T. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology. 47:1993;91-97.
2. Girouard H., Chulak C., LeJossec M., Lamontagne D., de Champlain J. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J Hypertens. 19:2001;1369-1377.
3. K-Laflamme A., Wu L., Foucart S., de Champlain J. Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens. 11:1998;219-229.
4. Arangino S, Cagnacci A, Angiolucci M, Vacca AMB, Longu G, Volpe A, Melis GB: Effects of melatonin on vascular reactivity, catecholamine levels and blood pressure in healthy men. Am J Cardiol 1999;83:1417-1419
5. Birau N., Peterssen U., Meyer C., Gottschalk J. Hypotensive effect of melatonin in essential hypertension. IRCS Med Sci. 9:1981;906.
6. Girouard H., Chulak C., LeJossec M., Lamontagne D., de Champlain J. Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats. J Hypertens. 21:2003;179-188.
7. Wu L., Wang R., de Champlain J. Enhanced inhibition by melatonin of alpha-adrenoceptor-induced aortic contraction and inositol phosphate production in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 16:1998;339-347.
8. Bucher B., Gauer F., Pevet P., Masson-Pevet M. Vasoconstrictor effects of various melatonin analogs on the rat tail artery in the presence of phenylephrine. J Cardiovasc Pharmacol. 33:1999;316-322.
9. Evans B.K., Mason R., Wilson V.G. Evidence for direct vasoconstrictor activity of melatonin in "pressurized" segments of isolated caudal artery from juvenile rats. Naunyn-Schmiedeberg's Arch Pharmacol. 346:1992;362-365.
10. Jameson M., Dai F.X., Luscher T., Skopec J., Diederich A., Diederich D. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension. 21:1993;280-288.
11. Wu L., de Champlain J. Inhibition by cyclic AMP of basal and induced inositol phosphate production in cultured aortic smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 14:1996;593-599.
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
13. Weekley L.B. Melatonin-induced relaxation of rat aorta interaction with adrenergic agonists. J Pineal Res. 11:1991;28-34.
14. Reyes-Toso C.F., Roson M.I., Albornoz L.E., Damiano P.F., Linares L.M., Cardinali D.P. Vascular reactivity in diabetic rats effect of melatonin. J Pineal Res. 33:2002;81-86.
15. Anwar M.M., Meki A.R., Rahma H.H. Inhibitory effects of melatonin on vascular reactivity possible role of vasoreactive mediators. Comp Biochem Physiol C Toxicol Pharmacol. 130:2001;357-367.
16. Wu R., Millette E., Wu L., de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 19:2001;741-748.
17. Katusic Z.S. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med. 20:1996;443-448.
18. Girouard H., Chulak C., Lejossec M., de Champlain J. N-acetylcysteine treatment improves NO and alpha-adrenergic pathways in mesenteric artery of spontaneously hypertensive rats. Am J Hypertens. 16:2003;577-584.
19. Martin W., Furchgott R.F., Villani G.M., Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. Pharmacol Exp Ther. 237:1986;443-448.
20. Storr M., Koppitz P., Sibaev A., Saur D., Kurjac M., Franck H., Schusdziarra V., Allescher H.D. Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res. 33:2002;101-108.
21. Reiter R.J., Tan D.X., Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline amelioration with melatonin. Mech Ageing Dev. 123:2002;1007-1019.
22. Okatani Y., Wakatsuki A., Morioka N., Watanabe K. Melatonin inhibits the vasorelaxant action of peroxynitrite in human umbilical artery. J Pineal Res. 27:1999;111-115.
23. Bharadwaj L.A., Prasad K. Mechanism of hydroxyl radical-induced modulation of vascular tone. Free Radic Biol Med. 22:1997;381-390.
24. Doolen S., Krause D.N., Dubocovitch M.L., Duckles S.P. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol. 345:1998;67-69.
25. Viswanathan M., Laitinen J.T., Saavedra J.M. Differential expression of melatonin receptors in spontaneously hypertensive rats. Neuroendocrinology. 56:1992;864-870.
26. Masana M.I., Doolen S., Ersahin C., Al-Ghoul W.M., Duckles S.P., Dubocovich M.L., Krause D.N. MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther. 302:2002;1295-1302.
27. Kennaway D.J., Voultsios A. Circadian rhythm of free melatonin in human plasma. J Clin Endocrinol Metab. 83:1998;1013-1015.
28. Finocchiaro L.M., Nahmod V.E., Launay J.M. Melatonin biosynthesis and metabolism in peripheral blood mononuclear leukocytes. Biochem J. 280:1991;727-731.
29. Slominski A., Baker J., Rosano T.G., Guisti L.W., Ermak G., Grande M., Gaudet S.J. Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem. 271:1996;12281-12286.
30. Viswanathan M., Laitinen J.T., Saavedra J.M. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci USA. 87:1990;6200-6203.
31. Poeggeler B., Thuermann S., Dose A., Schoenke M., Burkhardt S., Hardeland R. Melatonin's unique radical scavenging properties-roles of its functional substituents as revealed by a comparison with its structural analogs. J Pineal Res. 33:2002;20-30.
32. Miyamoto Y., Akaike T., Yoshida M., Goto S., Horie H., Maeda H. Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proc Soc Exp Biol Med. 211:1996;366-373.
33. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Sci USA. 88:1991;10045-10048.
34. Girouard H, Chulak C, LeJossec M, de Champlain J: N-acetylcysteine improves NO and α-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens 2003;16:577-584
35. Schnackenberg C.G., Welch W.J., Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic role of nitric oxide. Hypertension. 32:1998;59-64.